secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2024-09-10T23:59:59+00:00
Accession:  0001104659-24-098564
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie amends bylaws, deletes section 2.13(D)(iv) amid stockholder class action
-------------------------------------------------------------------------------

- Board approved Third Amended and Restated By-laws effective September 6, 2024.
- Amendments update registered agent address and delete Section 2.13(D)(iv) in its entirety.
- Company is defendant in a stockholder class action challenging Section 2.13(D)(iv).
- Company believes provision lawful but no longer of practical value; deletion avoids defending it.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465924098564/0001104659-24-098564-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465924098564/tm2423380d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-098564

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer